Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02017509 · ClinicalTrials.gov registry record
Immunoscore in Rectal Cancer
A clinical trial, sponsored by Providence Health & Services.
- Completed
- Registry status
- 3
- Enrollment target
NCT02017509 is a clinical trial that has completed, run by Providence Health & Services. The registered enrollment target is 3 participants.
The verdict
NCT02017509 has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- 3 participants
- Enrollment target
Study Summary
This is an observational study of tumor samples and MRI imaging in patients with colorectal cancers. A tumor sample, MRI scans, and treatment outcome data will be used for research purposes to see if it is possible to predict patients' response to treatment.
Interventions
- PROCEDURE Diagnostic Biopsy and Surgical Procedure
- PROCEDURE Intravoxel incoherent motion MRI (IVIM)
- PROCEDURE Dynamic Contrast Enhanced MRI (DCE-MRI)
- GENETIC RNA gene expression analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-01-24 |
| Est. Completion | 2018-07-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02017509
The ClinicalTrials.gov registry entry for NCT02017509 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Providence Health & Services, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Diagnostic Biopsy and Surgical Procedure is the first listed.
NCT02017509 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02017509 about?
NCT02017509 is a clinical study titled "Immunoscore in Rectal Cancer". This is an observational study of tumor samples and MRI imaging in patients with colorectal cancers. A tumor sample, MRI scans, and treatment outcome data will be used for research purposes to see if it is possible to predict patients' response to treatment.
What is the current status of trial NCT02017509?
This trial is currently completed. The enrollment target is 3 participants. The study started on 2014-01-24. Estimated completion is 2018-07-17.
What interventions are being tested in trial NCT02017509?
The interventions under investigation include: Diagnostic Biopsy and Surgical Procedure (PROCEDURE), Intravoxel incoherent motion MRI (IVIM) (PROCEDURE), Dynamic Contrast Enhanced MRI (DCE-MRI) (PROCEDURE), RNA gene expression analysis (GENETIC).
Who is sponsoring clinical trial NCT02017509?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.